Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Feb;2(1):45-51.
doi: 10.1586/14760584.2.1.45.

Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery

Affiliations
Review

Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery

Katri Jalava et al. Expert Rev Vaccines. 2003 Feb.

Abstract

The application of new strategies to develop effective vaccines is essential in modern medicine. The bacterial ghost system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures including bioadhesive properties. They are produced by PhiX174 protein E-mediated lysis of gram-negative bacteria. The intrinsic adjuvant properties of bacterial ghost preparations enhance immune responses against envelope-bound antigens, including T-cell activation and mucosal immunity. Since native and foreign antigens can be expressed in the envelope complex of ghosts before E-mediated lysis, multiple antigens of various origin can be presented to the immune system simultaneously. In addition, the extended bacterial ghost system represents a platform technology for specific targeting of DNA-encoded antigens to primary antigen-presenting cells. The potency, safety and relatively low production cost of bacterial ghosts offer a significant technical advantage, especially when used as combination vaccines.

PubMed Disclaimer

Similar articles

  • Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P, Mayr UB, Azimpour-Tabrizi C, Eko FO, Jechlinger W, Mayrhofer P, Alefantis T, Mujer CV, DelVecchio VG, Lubitz W. Walcher P, et al. Expert Rev Vaccines. 2004 Dec;3(6):681-91. doi: 10.1586/14760584.3.6.681. Expert Rev Vaccines. 2004. PMID: 15606353 Review.
  • Bacterial ghosts: non-living candidate vaccines.
    Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W. Szostak MP, et al. J Biotechnol. 1996 Jan 26;44(1-3):161-70. doi: 10.1016/0168-1656(95)00123-9. J Biotechnol. 1996. PMID: 8717400 Review.
  • Bacterial ghosts as adjuvant particles.
    Riedmann EM, Kyd JM, Cripps AW, Lubitz W. Riedmann EM, et al. Expert Rev Vaccines. 2007 Apr;6(2):241-53. doi: 10.1586/14760584.6.2.241. Expert Rev Vaccines. 2007. PMID: 17408373 Review.
  • Bacterial ghosts as multifunctional vaccine particles.
    Szostak MP, Mader H, Truppe M, Kamal M, Eko FO, Huter V, Marchart J, Jechlinger W, Haidinger W, Brand E, Denner E, Resch S, Dehlin E, Katinger A, Kuen B, Haslberger A, Hensel A, Lubitz W. Szostak MP, et al. Behring Inst Mitt. 1997 Feb;(98):191-6. Behring Inst Mitt. 1997. PMID: 9382740
  • Bacterial ghosts as antigen delivery vehicles.
    Mayr UB, Walcher P, Azimpour C, Riedmann E, Haller C, Lubitz W. Mayr UB, et al. Adv Drug Deliv Rev. 2005 Jun 17;57(9):1381-91. doi: 10.1016/j.addr.2005.01.027. Epub 2005 Apr 20. Adv Drug Deliv Rev. 2005. PMID: 15878634 Review.

Cited by

Publication types

MeSH terms

LinkOut - more resources